CCL2/CCR2 inhibition in atherosclerosis: a meta-analysis of preclinical studies
L. Zivkovic, Y. Asare, J. Bernhagen, M. Dichgans, M. K. Georgakis
This paper meta-analyzes preclinical studies on CCL2/CCR2 inhibition in atherosclerosis, finding it reduces lesion size and stabilizes plaques across multiple vascular sites and models.
bioRxiv · Apr 16, 2021 · PreprintImmunology